Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study
Background and objective Moyamoya disease (MMD) is an increasingly recognised cause of stroke, mainly described in East Asia. China is the largest nation in Asia, but few studies reported the epidemiology of MMD, especially at a national level. We aimed to estimate the incidence and prevalence of MM...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
|
Series: | Stroke and Vascular Neurology |
Online Access: | https://svn.bmj.com/content/early/2021/05/03/svn-2021-000909.full |
id |
doaj-f5f9f57762a245eb98e355cd6964903a |
---|---|
record_format |
Article |
spelling |
doaj-f5f9f57762a245eb98e355cd6964903a2021-05-05T14:30:03ZengBMJ Publishing GroupStroke and Vascular Neurology2059-869610.1136/svn-2021-000909Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort studyLu Chen0Pei Gao1Siyan Zhan2Shengfeng Wang3Jingnan Feng4Guozhen Liu5Jinxi Wang6Zheng Yang7Yixin Sun8Guoyu Zhou9Qingliang Wang10Junyou Yu11Xiwang Yang12Department of Neurology, Peking University Third Hospital, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaPeking University Health Information Technology Co. Ltd, Beijing, ChinaBeijing Healthcom Data Technology Co. Ltd, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Geriatric Neurology, Qilu Hospital of Shandong University, Jinan, ChinaDepartment of Medical Affairs, Qilu Hospital of Shandong University, Jinan, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaBackground and objective Moyamoya disease (MMD) is an increasingly recognised cause of stroke, mainly described in East Asia. China is the largest nation in Asia, but few studies reported the epidemiology of MMD, especially at a national level. We aimed to estimate the incidence and prevalence of MMD in China.Methods We performed a population-based study using data from the national databases of Urban Basic Medical Insurance between 2013 and 2016, covering approximately 0.50 billion individuals. MMD cases were identified by diagnostic code (International Classification of Diseases, 10th Revision I67.5) or related diagnostic text.Results A total of 1987 MMD patients (mean age 44.45±14.30 years, female-to-male ratio 1.12) were identified, representing a national crude incidence of 0.59 (95% CI: 0.49 to 0.68) and a prevalence of 1.01 (95% CI: 0.81 to 1.21) per 100 000 person-years in 2016. Rates were higher in females than in males for the incidence (0.66 vs 0.52) and prevalence (1.05 vs 0.90). And the age-specific rates showed a bimodal distribution, with the highest peak in middle-aged group and the second peak in child group.Conclusions Our results confirm that MMD is relatively common in East Asians, but the rates in China were lower than those in other East Asian countries such as Japan and Korea. The unique epidemiological features, including a relatively weak female predominance and a shift in the highest peak of incidence from children to adults, revealed new sight into MMD. Further research is expected to explore the potential pathogenesis of MMD.https://svn.bmj.com/content/early/2021/05/03/svn-2021-000909.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lu Chen Pei Gao Siyan Zhan Shengfeng Wang Jingnan Feng Guozhen Liu Jinxi Wang Zheng Yang Yixin Sun Guoyu Zhou Qingliang Wang Junyou Yu Xiwang Yang |
spellingShingle |
Lu Chen Pei Gao Siyan Zhan Shengfeng Wang Jingnan Feng Guozhen Liu Jinxi Wang Zheng Yang Yixin Sun Guoyu Zhou Qingliang Wang Junyou Yu Xiwang Yang Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study Stroke and Vascular Neurology |
author_facet |
Lu Chen Pei Gao Siyan Zhan Shengfeng Wang Jingnan Feng Guozhen Liu Jinxi Wang Zheng Yang Yixin Sun Guoyu Zhou Qingliang Wang Junyou Yu Xiwang Yang |
author_sort |
Lu Chen |
title |
Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study |
title_short |
Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study |
title_full |
Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study |
title_fullStr |
Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study |
title_full_unstemmed |
Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study |
title_sort |
incidence and prevalence of moyamoya disease in urban china: a nationwide retrospective cohort study |
publisher |
BMJ Publishing Group |
series |
Stroke and Vascular Neurology |
issn |
2059-8696 |
description |
Background and objective Moyamoya disease (MMD) is an increasingly recognised cause of stroke, mainly described in East Asia. China is the largest nation in Asia, but few studies reported the epidemiology of MMD, especially at a national level. We aimed to estimate the incidence and prevalence of MMD in China.Methods We performed a population-based study using data from the national databases of Urban Basic Medical Insurance between 2013 and 2016, covering approximately 0.50 billion individuals. MMD cases were identified by diagnostic code (International Classification of Diseases, 10th Revision I67.5) or related diagnostic text.Results A total of 1987 MMD patients (mean age 44.45±14.30 years, female-to-male ratio 1.12) were identified, representing a national crude incidence of 0.59 (95% CI: 0.49 to 0.68) and a prevalence of 1.01 (95% CI: 0.81 to 1.21) per 100 000 person-years in 2016. Rates were higher in females than in males for the incidence (0.66 vs 0.52) and prevalence (1.05 vs 0.90). And the age-specific rates showed a bimodal distribution, with the highest peak in middle-aged group and the second peak in child group.Conclusions Our results confirm that MMD is relatively common in East Asians, but the rates in China were lower than those in other East Asian countries such as Japan and Korea. The unique epidemiological features, including a relatively weak female predominance and a shift in the highest peak of incidence from children to adults, revealed new sight into MMD. Further research is expected to explore the potential pathogenesis of MMD. |
url |
https://svn.bmj.com/content/early/2021/05/03/svn-2021-000909.full |
work_keys_str_mv |
AT luchen incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT peigao incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT siyanzhan incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT shengfengwang incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT jingnanfeng incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT guozhenliu incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT jinxiwang incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT zhengyang incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT yixinsun incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT guoyuzhou incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT qingliangwang incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT junyouyu incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy AT xiwangyang incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy |
_version_ |
1721460085078622208 |